hrs4r
 I want to donate

The Precision Oncology research group in Girona (OncoGiR_Pro) is made up of researchers who are members of the ICO Girona Medical Oncology Service and collaborators from other services, located at the Hospital Dr. Josep Trueta. Led by Dr. Joan Brunet, and with Dr. Joaquim Bosch as Scientific Coordinator, the research group's mission is to integrate clinical, epidemiological and translational research in the field of precision oncology. The aim is to develop new therapeutic strategies and identify biomarkers for predicting the risk and clinical course of various cancers.

Main lines of research
  • Clinical development of new drugs, biomarkers for predicting response to treatment and clinical evolution, genetic basis of hereditary cancer, cancer risk prediction models.

These lines of research apply to different tumours: breast, digestive, thoracic, urological, skin, ENT and gynaecological.

Strategic objectives
  • Mission: To integrate clinical, epidemiological and translational research in the field of precision oncology.
  • Goal: To develop new therapeutic strategies and identify biomarkers for the prediction of risk and clinical evolution of different cancers.
Publications
0

Cancer risks by sex and variant type in PTEN Hamartoma Tumor Syndrome.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115, 93-103 dx.doi.org/10.1093/jnci/djac188
0

Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.

LANCET ONCOLOGY, 2023, 24, 91-106 dx.doi.org/10.1016/S1470-2045(22)00643-X

Sánchez A, Roos VH, Navarro M, Pineda M, Caballol B, Moreno L, Carballal S, Rodríguez-Alonso L, Ramon Y Cajal T, Llort G, Piñol V, Fernandez AL, Salces I, Picó MD, Rivas L, Bujanda L, Garzon M, Pizarro A, Martinez de Castro E, López-Arias MJ, Poves C, Garau C, Rodriguez-Alcalde D, Herraiz M, Alvarez-Urrutia C, Dacal A, Carrillo-Palau M, Cid L, Ponce M, Barreiro-Alonso E, Saperas E, Aguirre E, Romero C, Bastiaansen B, Gonzalez-Acosta M, Morales-Romero B, Ocaña T, Rivero-Sánchez L, Jung G, Bessa X, Cubiella J, Jover R, Rodríguez-Moranta F, Balmaña J, Brunet J, Castells A, Dekker E, Capella G, Serra-Burriel M, Moreira L, Pellise M, Balaguer F

Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20, 611 dx.doi.org/10.1016/j.cgh.2020.11.002

OnCovid Study Group, Pinato DJ, Patel M, Scotti L, Colomba E, Dolly S, Loizidou A, Chester J, Mukherjee U, Zambelli A, Dalla Pria A, Aguilar-Company J, Bower M, Salazar R, Bertuzzi A, Brunet J, Lambertini M, Tagliamento M, Pous A, Sita-Lumsden A, Srikandarajah K, Colomba J, Pommeret F, Seguí E, Generali D, Grisanti S, Pedrazzoli P, Rizzo G, Libertini M, Moss C, Evans JS, Russell B, Harbeck N, Vincenzi B, Biello F, Bertulli R, Ottaviani D, Liñan R, Rossi S, Carmona-García MC, Tondini C, Fox L, Baggi A, Fotia V, Parisi A, Porzio G, Queirolo P, Cruz CA, Saoudi-Gonzalez N, Felip E, Roqué Lloveras A, Newsom-Davis T, Sharkey R, Roldán E, Reyes R, Zoratto F, Earnshaw I, Ferrante D, Marco-Hernández J, Ruiz-Camps I, Gaidano G, Patriarca A, Bruna R, Sureda A, Martinez-Vila C, Sanchez de Torre A, Berardi R, Giusti R, Mazzoni F, Guida A, Rimassa L, Chiudinelli L, Franchi M, Krengli M, Santoro A, Prat A, Tabernero J, Van Hemelrijck M, Diamantis N, Gennari A, Cortellini A

Time-Dependent COVID-19 Mortality in Patients With Cancer An Updated Analysis of the OnCovid Registry

JAMA Oncology, 2022, 8, 114-122 dx.doi.org/10.1001/jamaoncol.2021.6199

Carbó-Bagué A, Rubió-Casadevall J, Puigdemont M, Sanvisens A, Oliveras G, Coll M, Del Olmo B, Perez-Bueno F, Marcos-Gragera R

Epidemiology and Molecular Profile of Mucosal Melanoma: A Population-Based Study in Southern Europe

Cancers, 2022, 14 dx.doi.org/10.3390/cancers14030780
0

No Excess Mortality up to 10 Years in Early Stages of Breast Cancer in Women Adherent to Oral Endocrine Therapy: A Probabilistic Graphical Modeling Approach

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 dx.doi.org/10.3390/ijerph19063605
Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona Precision Oncology in Girona

Rueda Domínguez A, Cirauqui B, García Castaño A, Alvarez Cabellos R, Carral Maseda A, Castelo Fernández B, Iglesias Rey L, Rubió-Casadevall J, Arrazubi V, Mesía R

SEOM-TTCC clinical guideline in nasopharynx cancer (2021).

CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24, 670-680 dx.doi.org/10.1007/s12094-022-02814-x

Rubió-Casadevall J, Ciurana E, Puigdemont M, Sanvisens A, Marruecos J, Miró J, Urban A, Palhua RL, Martín-Romero F, Ortiz-Duran MR, Marcos-Gragera R

Population-Based Analysis of Trends in Incidence and Survival of Human Papilloma Virus-Related Oropharyngeal Cancer in a Low-Burden Region of Southern Europe

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 dx.doi.org/10.3390/ijerph19084802
0

Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism

NATURE MEDICINE, 2022, 28, 752-765 dx.doi.org/10.1038/s41591-022-01749-8
0

COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114, 979-987 dx.doi.org/10.1093/jnci/djac057
Competitive projects
Codi oficial: La Marató 201906-30 Start date:30/09/2020 Data fi: 29/09/2023 Investigador/a principal: JOAQUIM BOSCH BARRERA Organisme finançador: FUNDACIO LA MARATO TV3 Ajuda: 109,562.50 €
Codi oficial: Pfizer 2019 Joaquim Bosch Start date:05/07/2019 Data fi: 30/06/2023 Investigador/a principal: JOAQUIM BOSCH BARRERA Organisme finançador: PFIZER, S.L.U. Ajuda: 97,750 €
Codi oficial: Tumor microenvironment of brain metastases Start date:01/12/2022 Data fi: 30/11/2025 Investigador/a principal: JOAQUIM BOSCH BARRERA Organisme finançador: ASSOCIACIÓ ESPANYOLA CONTRA EL CÀNCER Ajuda: 105,000 €
Codi oficial: VEGF/EGFR Start date:11/06/2022 Data fi: 10/06/2024 Investigador/a principal: XAVIER HERNÁNDEZ YAGÜE Organisme finançador: FUNDACIÓ ACADÈMIA CIÈNCIES MÈDIQUES Ajuda: 6,000 €
Job offers

Team

If you are a researcher and you are interested in collaborating with any of our research groups, please fill in this form.
I am interested in
If you are a student or you want to do an internship with any of our research groups, please fill in this form.
I am interested in

About IDIBGI!

menu